Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 271-280 of 283 for Lung cancer

Edit search filters
  1. Study Of RYZ101 In Combination With SoC In Subjects With SSTR+ ES-SCLC

    Jacksonville, FL, Rochester, MN

  2. Identification Of A Plasma Proteomic Signature For Lung Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

  3. Study To Evaluate The Safety, Tolerability & Efficacy Of TNG462 In Combination In PDAC & NSCLC Patients

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  4. A Study Of Bronchoalveolar Lavage Fluid Biorepository For Biomarker Discovery In Lung Cancer

    Jacksonville, FL

  5. Survey Study On Patient Reported Outcomes For Small Cell Lung Cancer

    Scottsdale/Phoenix, AZ

  6. A Study Of VENTANA TROP2 (EPR20043) Device In Non-Small Cell Lung Cancer (NSCLC)

    Rochester, MN

  7. Isolating And Testing Circulating Tumor DNA And Soluble Immune Markers During The Course Of Treatment For Lung Cancer

    Rochester, MN

  8. A Study To Evaluate Maximizing Anti-PD-1 Therapy By Monitoring T Cell Responses In Melanoma, Lung And Other Cancer Types

    Jacksonville, FL, Rochester, MN

  9. Cell Free DNA (Cfdna) Blood Assays For The Detection Of EGFR And Other Clinically Relevant Gene Mutations In Patients With Non-Small Cell Lung Cancer

    Rochester, MN

  10. Immune Responses In Prostate, Lung, Melanoma And Breast Cancer Patients Following Stereotactic Body Radiotherapy (SBRT), Intensity Modulated Radiotherapy (IMRT) Or Brachytherapy

    Rochester, MN

.

Mayo Clinic Footer